Preventing HIV Transmission in Macaques with Antiretroviral Therapy
Author Information
Author(s): Myron S. Cohen, Angela D. M. Kashuba
Primary Institution: University of North Carolina at Chapel Hill
Hypothesis
Can antiretroviral pre-exposure prophylaxis regimens effectively prevent HIV transmission in macaques?
Conclusion
The study found that certain antiretroviral regimens provided complete protection against HIV infection in macaques.
Supporting Evidence
- Four out of six macaques became infected with FTC alone.
- Two out of six macaques became infected with a combination of FTC and TDF.
- None of the twelve macaques receiving a specific dosing regimen became infected.
Takeaway
Researchers tested different medicines to see if they could stop monkeys from getting a virus similar to HIV, and some combinations worked really well.
Methodology
Macaques were exposed to weekly rectal virus challenges for up to 14 weeks while receiving various antiretroviral PrEP regimens.
Potential Biases
The use of historical controls may introduce bias in the results.
Limitations
The study had small sample sizes, used historical controls, and the drug doses were higher than those typically seen in humans.
Participant Demographics
Macaques were used as the study subjects.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website